{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T06:29:21Z","timestamp":1744352961514},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s10165-010-0365-8","type":"journal-article","created":{"date-parts":[[2010,10,7]],"date-time":"2010-10-07T11:04:44Z","timestamp":1286449484000},"page":"215-218","source":"Crossref","is-referenced-by-count":20,"title":["Successful tocilizumab treatment in a patient with adult-onset Still\u2019s disease complicated by chronic active hepatitis B and amyloid A amyloidosis"],"prefix":"10.1093","volume":"21","author":[{"given":"Dai","family":"Kishida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuaki","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Takebayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Matoba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Jouyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Mokuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Takasugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,10,8]]},"reference":[{"key":"365_CR1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/ard.30.2.121","volume":"30","author":"EGL Bywaters","year":"1971","unstructured":"Bywaters EGL. Still\u2019s disease in the adult. Ann Rheum Dis. 1971;30:121\u201333.","journal-title":"Ann Rheum Dis"},{"key":"365_CR2","first-page":"424","volume":"29","author":"M Yamaguchi","year":"1992","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwazaki S, et al. Preliminary criteria for classification of adult Still\u2019s disease. J Rheumatol. 1992;29:424\u201330.","journal-title":"J Rheumatol"},{"key":"365_CR3","first-page":"2189","volume":"31","author":"DY Chen","year":"2004","unstructured":"Chen DY, Lan JL, Lin FJ, Hsieh TY. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still\u2019s disease. J Rheumatol. 2004;31:2189\u201398.","journal-title":"J Rheumatol"},{"key":"365_CR4","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","volume":"371","author":"S Yokota","year":"2008","unstructured":"Yokota S, Imagawa T, Mori M, Miyamae T, Aihara Y, Takei S, et al. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet. 2008;371:998\u20131006.","journal-title":"Lancet"},{"key":"365_CR5","unstructured":"Tsubouchi H, Kumada H, Kiyosawa K, Mochida S, Sakaida I, Tanaka E, et al. Prevention of immunosuppressive therapy or chemotherapy-induced reactivation of hepatitis B virus infection\u2014joint report of intractable liver diseases study group of Japan and Japanese study group of standard antiviral therapy for viral hepatitis. Kanzo. 2009;50:38\u201342."},{"key":"365_CR6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/art.1780300209","volume":"30","author":"JJ Cush","year":"1987","unstructured":"Cush JJ, Medsger TA Jr, Christy WC, Herbert DC, Cooperstein LA. Adult-onset Still\u2019s disease. Clinical course and outcome. Arthritis Rheum. 1987;30:186\u201394.","journal-title":"Arthritis Rheum"},{"key":"365_CR7","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1002\/art.10620","volume":"46","author":"M Iwamoto","year":"2002","unstructured":"Iwamoto M, Nara H, Hirata D, Minota S, Nishimoto N, Yoshizaki K. Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still\u2019s disease. Arthritis Rheum. 2002;46:3388\u20139.","journal-title":"Arthritis Rheum"},{"key":"365_CR8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10165-008-0116-2","volume":"19","author":"H Nakahara","year":"2009","unstructured":"Nakahara H, Mima T, Yoshio-Hoshino N, Matsushita M, Hashimoto J, Nshimoto N. A case report of a patient with refractory adult-onset Still\u2019s disease who was successfully treated with tocilizumab over 6\u00a0years. Mod Rheumatol. 2009;19:69\u201372.","journal-title":"Mod Rheumatol"},{"key":"365_CR9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10067-009-1097-z","volume":"28","author":"K Matsumoto","year":"2009","unstructured":"Matsumoto K, Nagashima T, Takatori S, Kawahara Y, Yagi M, Iwamoto M, et al. Glucocorticoid and cyclosporine refractory adult onset Still\u2019s disease successfully treated with tocilizumab. Clin Rheumatol. 2009;28:485\u20137.","journal-title":"Clin Rheumatol"},{"key":"365_CR10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ard.2008.088179","volume":"68","author":"M Bandt De","year":"2009","unstructured":"De Bandt M, Saint-Marcoux B. Tocilizumab for multirefractory adult-onset Still\u2019s disease. Ann Rheum Dis. 2009;68:153\u20134.","journal-title":"Ann Rheum Dis"},{"key":"365_CR11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/ard.2004.024026","volume":"64","author":"B Fautrel","year":"2005","unstructured":"Fautrel B, Sibilia J, Mariette X, Combe B. Tumour necrosis factor alpha blocking agents in refractory adult Still\u2019s disease: an observational study of 20 cases. Ann Rheum Dis. 2005;64:262\u20136.","journal-title":"Ann Rheum Dis"},{"key":"365_CR12","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1002\/art.22118","volume":"54","author":"Y Okuda","year":"2006","unstructured":"Okuda Y, Takasugi K. Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis. Arthritis Rheum. 2006;54:2997\u20133000.","journal-title":"Arthritis Rheum"},{"key":"365_CR13","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/ard.2005.043257","volume":"65","author":"LH Calabrese","year":"2006","unstructured":"Calabrese LH, Zein NN, Vassilopoulos D. Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies. Ann Rheum Dis. 2006;65:983\u20139.","journal-title":"Ann Rheum Dis"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10165-010-0365-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:25:10Z","timestamp":1646843110000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-010-0365-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,8]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["365"],"URL":"https:\/\/doi.org\/10.1007\/s10165-010-0365-8","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,8]]}}}